
Fosfestrol sodium 300mg per 5ml Injection
Fosfestrol tetrasodium 300 mg per 5 ml injection having brand name as Honvan 300 mg per 5 ml injection, is an anti-cancer drug.
Various uses of Fosfestrol tetrasodium 300 mg per 5 ml injection are:
Given orally, dosage of Honvan 300 mg per 5 ml injection varies from person to person.
Side effects caused by Fosfestrol tetrasodium 300 mg per 5 ml injection do not require any medical treatment but you need to see your doctor if any of the below listed symptoms persists:
Although side effects disappear after some time but some precautions need to be taken while having Honvan 300 mg per 5 ml injection such as:
Several benefits of Fosfestrol tetrasodium 300 mg per 5 ml injection are:
Storage conditions for Honvan 300 mg per 5 ml injection are:
If expired do not use it rather discard it properly.
1. What is Honvan?
Honvan is an anti-cancer medicine containing Fosfestrol tetrasodium 120 mg in tablet form. It is an estrogen-based hormonal therapy primarily used in the management of prostate cancer. Lotus International lists Honvan under its Anti Cancer product category.
2. What is Honvan used for?
Honvan (Fosfestrol tetrasodium) is primarily used in the treatment of prostate cancer as a form of hormonal therapy. Fosfestrol can help reduce androgen-related hormonal stimulation that may contribute to the growth of hormone-sensitive prostate cancer.
3. How does Honvan work?
Fosfestrol has estrogenic activity and can suppress the hormonal signals responsible for testosterone production and activity. Reducing androgenic stimulation may help slow the progression of certain hormone-sensitive prostate cancer cells.
4. What strength of Honvan is available?
Lotus International lists Fosfestrol tetrasodium 120 mg tablets under the Honvan brand. Product availability, packaging and supply conditions may vary according to the destination market and applicable pharmaceutical regulations.
5. What are the possible side effects of Honvan?
Possible side effects may include nausea, vomiting, breast enlargement or tenderness, abdominal discomfort, dizziness, appetite changes and circulatory complications such as blood clots. Patients should be monitored by a healthcare professional for persistent or serious reactions.